Report
Valens Research

ENTG - Embedded Expectations Analysis - 2020 12 07

Entegris, Inc. (ENTG:USA) currently trades at a historical high relative to UAFRS-based (Uniform) earnings, with a 29.6x Uniform P/E. At these levels, the market has bullish expectations for the firm, but management may be concerned about Torrento and Protego, their AMH division, and the potential of their GMTI acquisition

Specifically, management may lack confidence in their ability to sustain the strength of their AMH division, develop potential solutions for their new fab projects, and maintain mainstream fabs recovery. They may also have concerns about their current capex mix position, the potential of Global Measurement Technologies (GMTI), and macroeconomic headwinds. Furthermore, they may lack confidence in their ability to sustain stable conditions in the memory segment, achieve new records with Torrento and Protego, and transform most of their 3D NAND wafers into 96-plus layers. Management may also have concerns about their ability to sustain high volumes, control costs, and secure better R&D opportunities
Underlying
Entegris Inc.

Entegris is a developer, manufacturer and supplier of microcontamination control products, chemicals and materials handling solutions for manufacturing processes in the semiconductor and other industries. The company has three segments: Specialty Chemicals and Engineered Materials, which provides process chemistries, gases, and materials; Microcontamination Control, which provides solutions to filter and purify liquid chemistries and gases used in semiconductor manufacturing processes and other industries; and Advanced Materials Handling segment, which develops solutions to monitor, protect, transport, and deliver liquid chemistries, wafers and substrates.

Provider
Valens Research
Valens Research

In 2009, just as the dust was settling from the last major equity and credit market crises, we launched a boutique research firm with the intention of breaking Wall Street’s biases and broken incentives:

  • GAAP and IFRS have failed to provide rules for reliable financial statement reporting
  • Stock analyst recommendations are not grounded in disciplined financial analysis
  • Credit agencies have been set up to grossly fail in their responsibilities to investors and the public markets
  • Utter lack of willingness of major research firms to employ the the most advanced forensic analysis available

We sought to provide investors and company analysts with a source of information that changed all that.
Many years later, our business model remains because little has changed on Wall Street.

  • Corporate credit ratings remain years behind the fundamental underpinnings of company performance
  • Stock analysts continue to make recommendations with deeply inherent biases
  • Research firms have failed to break down the walls between credit, equity, and macroeconomic research
  • The governing accounting bodies have created more leeway for mis-estimates and mis-classifications as financials have become unwieldy and overwhelming

The integrity of Valens Research is founded in our disciplined processes and analytics. No “star” analysts. No corporate advisory relationships. No-nonsense opinions and recommendations.

Analysts
Valens Research

Other Reports on these Companies
Other Reports from Valens Research

ResearchPool Subscriptions

Get the most out of your insights

Get in touch